国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

Business / Companies

Novozymes bets big on microbial products

By Li Xiang in Tianjin (China Daily) Updated: 2014-09-12 07:24

Denmark-based biotechnology giant Novozymes is anticipating huge demand for its microbial products that improve crop yields in China, the world's largest producer and consumer of agricultural goods, a top company official said on Thursday.

The company has already started field trials for its microbial technology in China and expects to commercialize the technology soon, said Peder Holk Nielsen, chief executive officer of the Danish company, which specializes in industrial enzymes.

The company has also teamed up with the world's largest seed company Monsanto Co and formed a $300 million strategic alliance to jointly develop and commercialize microbial technology worldwide.

Novozymes bets big on microbial products
Better funding plans vital for biotech firms
 
Novozymes bets big on microbial products
Novozymes tops DJSI for 12th time
Microbial-based products are those derived from naturally occurring micro-organisms such as bacteria and fungi, which can be applied to seeds before planting to enhance crop productivity with less input and also to help control pests and diseases.

Nielsen said the microbial technology has promising prospects in China as the country is looking for sustainable growth options. China is facing pressing challenges in agricultural production like shrinking arable land and water shortages due to increasing industrialization and environmental degradation.

"The main market for microbial technology is presently in the US and Latin America. But it is obvious that we can bring the technology to Asian countries like China," Nielsen told China Daily on the sidelines of the World Economic Forum in Tianjin.

Northern China will be the "first goal" of Novozymes to apply the technology as it delivers better results in large-scale farmlands, Nielsen said.

The CEO anticipates no major regulatory hurdle for its technology to enter the Chinese market as the process releases naturally occurring microorganisms into the soil and does not involve any genetic modification technology.

But Nielsen said Novozymes wants to remain modest in China as the research is still in the initial stages and question marks remain about whether the technology could fit with different types of soil and various kinds of crops in China.

In the US, the company has done 170,000 field trials under its partnership with Monsanto and the same will go up to 500,000 by 2016, Nielsen said.

Biologicals are used to complement or replace agricultural chemical products and represent a growing market segment of roughly $2.3 billion in annual sales, according to Monsanto, which is leveraging its vast field-testing and marketing capabilities to promote the products worldwide.

Nielsen said Novozymes will continue to grow its business in China as a leading supplier of industrial biological solutions by recruiting more local employees, but he sees no immediate need for capital investment.

Hot Topics

Editor's Picks
...
...
西昌市| 渝北区| 铜梁县| 罗平县| 贵阳市| 宜黄县| 唐山市| 左贡县| 当阳市| 伊金霍洛旗| 西安市| 成武县| 唐海县| 揭西县| 开原市| 武胜县| 杭州市| 富源县| 池州市| 花莲县| 华安县| 玉树县| 上饶县| 碌曲县| 江阴市| 古蔺县| 涿州市| 永安市| 临沧市| 收藏| 铅山县| 临潭县| 长兴县| 山丹县| 呼和浩特市| 会东县| 集安市| 上饶市| 仪陇县| 萨迦县| 高平市|